IN THE UNITED STATES DISTRICT COURTFOR THE DISTRICT OF DELAWAREVERTICAL ANALYTICS LLC,Plaintiff,v.BRUKER-AXS, INC., PFIZER, INC.,
PHARMACEUTICALS LP,ASTRAZENECA LP and BRISTOL-MYERSSQUIBB CO.,Defendants.
Civil Action No. 12-1187-GMSWHEREAS presently before the court is the defendant's Motion for Stay (D.I. 36), whichalternatively moves that the court limit discovery from the Customers
:wlfEREAS the court, having considered the parties' papers relating to the defendant'sMotion· for Stay, as well as the applicable law, con.eludes that a limited stay
discovery fromthe Customers is appropriate in this case;IT
HEREBY ORDERED THAT:
The defendants' Motion to Stay (D.I. 36) is GRANTED IN PART and DENIEDIN PART, such that the defendants' Motion to Stay the litigation is DENIED, and itsMotion to Limit Discovery from the Customers is GRANTED;2. Discovery against the Customers is STAYED until plaintiff, Vertical AnalyticsLLC, demonstrates it needs such discovery because the information obtained from
The court adopts the defendants' nomenclature, such that, the term "Customers" refers only to the followingdefendants: Pfizer, Inc., AstraZeneca PLC, AstraZeneca Pharmaceuticals LP, AstraZeneca LP, and Bristol-MyersSquibb Co.
Case 1:12-cv-01187-GMS Document 75 Filed 09/27/13 Page 1 of 2 PageID #: 739